Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.888 SEK | -1.11% |
|
-2.20% | -27.80% |
06-28 | Nanexa AB Announces Chief Financial Officer Changes | CI |
06-11 | Nanexa AB Announces That First Patient Dosed in Nanexa's Phase I Trial of NEX-22 in Type 2 Diabetes | CI |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
NANEXA AB | Drug Delivery Systems | -1.11% | -2.20% | -27.80% | -73.33% | -90.83% | 11.49M | - | - | - |
Technical Rankings Surperformance
- Stock Market
- Equities
- NANEXA Stock
- Charts Nanexa AB
- Comparison Chart